Lack of genetic association of neutral endopeptidase (NEP) with complex regional pain syndrome (CRPS)

Neuroscience Letters

Volumn 472, Issue 1, 2010, Pages 19-23

  Huehne, Kathrin ^a   Schaal, Ute ^a   Leis, Stefan ^a,b   Uebe, Steffen ^a   Gosso, M Florencia ^c   van den Maagdenberg, Arn M J M ^c   Maihöfner, Christian ^a   Birklein, Frank ^d   Rautenstrauss, Bernd ^a,e   Winterpacht, Andreas ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b Christian Doppler Klinik   (Austria)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e MGZ   (Germany)

Author keywords

Association; CRPS; NEP; Pain

Indexed keywords

MEMBRANE METALLOENDOPEPTIDASE; NEUROPEPTIDE;

ADULT; ALLELE; ARTICLE; COMPLEX REGIONAL PAIN SYNDROME; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

5' FLANKING REGION; ADULT; CASE-CONTROL STUDIES; COMPLEX REGIONAL PAIN SYNDROMES; DINUCLEOTIDE REPEATS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NEPRILYSIN; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 76949108027     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.01.044     Document Type: Article

References (38)

1. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
2. Bennett G.J., and Harden R.N. Questions concerning the incidence and prevalence of complex regional pain syndrome type I (RSD). Pain 106 (2003) 209-210 (author reply 210-201)
3. Birklein F. Complex regional pain syndrome. J. Neurol. 252 (2005) 131-138
4. Birklein F., Schmelz M., Schifter S., and Weber M. The important role of neuropeptides in complex regional pain syndrome. Neurology 57 (2001) 2179-2184
5. Bruehl S., Harden R.N., Galer B.S., Saltz S., Backonja M., and Stanton-Hicks M. Complex regional pain syndrome: are there distinct subtypes and sequential stages of the syndrome?. Pain 95 (2002) 119-124
6. Comings D.E., Dietz G., Gade-Andavolu R., Blake H., Muhleman D., Huss M., Saucier G., and MacMurray J.P. Association of the neutral endopeptidase (MME) gene with anxiety. Psychiatr. Genet. 10 (2000) 91-94
7. de Mos M., Huygen F.J., Stricker B.H., Dieleman J.P., and Sturkenboom M.C. The association between ACE inhibitors and the complex regional pain syndrome: suggestions for a neuro-inflammatory pathogenesis of CRPS. Pain 142 (2009) 218-224
8. de Rooij A.M., de Mos M., Sturkenboom M.C., Marinus J., van den Maagdenberg A.M., and van Hilten J.J. Familial occurrence of complex regional pain syndrome. Eur. J. Pain 13 (2009) 171-177
9. de Rooij A.M., Florencia Gosso M., Haasnoot G.W., Marinus J., Verduijn W., Claas F.H., van den Maagdenberg A.M., and van Hilten J.J. HLA-B62 and HLA-DQ8 are associated with complex regional pain syndrome with fixed dystonia. Pain 145 (2009) 82-85
10. Erdos E.G., and Skidgel R.A. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J. 3 (1989) 145-151
11. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., Higgins J., DeFelice M., Lochner A., Faggart M., Liu-Cordero S.N., Rotimi C., Adeyemo A., Cooper R., Ward R., Lander E.S., Daly M.J., and Altshuler D. The structure of haplotype blocks in the human genome. Science 296 (2002) 2225-2229
12. Guo T.Z., Offley S.C., Boyd E.A., Jacobs C.R., Kingery W.S., and Substance. P signaling contributes to the vascular and nociceptive abnormalities observed in a tibial fracture rat model of complex regional pain syndrome type I. Pain 108 (2004) 95-107
13. HapMap. The International HapMap Project. Nature 426 (2003) 789-796
14. Harden R.N., and Bruehl S.P. Diagnosis of complex regional pain syndrome: signs, symptoms, and new empirically derived diagnostic criteria. Clin. J. Pain 22 (2006) 415-419
15. Harden R.N., Bruehl S., Stanton-Hicks M., and Wilson P.R. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med. 8 (2007) 326-331
16. Helisalmi S., Hiltunen M., Vepsalainen S., Iivonen S., Mannermaa A., Lehtovirta M., Koivisto A.M., Alafuzoff I., and Soininen H. Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients. J. Neurol. Neurosurg. Psychiatry 75 (2004) 1746-1748
17. Kemler M.A., van de Vusse A.C., van den Berg-Loonen E.M., Barendse G.A., van Kleef M., and Weber W.E. HLA-DQ1 associated with reflex sympathetic dystrophy. Neurology 53 (1999) 1350-1351
18. Kingery W.S., Davies M.F., and Clark J.D. A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II. Pain 104 (2003) 75-84
19. Kramer H.H., He L., Lu B., Birklein F., and Sommer C. Increased pain and neurogenic inflammation in mice deficient of neutral endopeptidase. Neurobiol. Dis. 35 (2009) 177-183
20. Kramer H.H., Schmidt K., Leis S., Schmelz M., Sommer C., and Birklein F. Inhibition of neutral endopeptidase (NEP) facilitates neurogenic inflammation. Exp. Neurol. 195 (2005) 179-184
21. Leis S., Weber M., Isselmann A., Schmelz M., and Birklein F. Substance-P-induced protein extravasation is bilaterally increased in complex regional pain syndrome. Exp. Neurol. 183 (2003) 197-204
22. Leis S., Weber M., Schmelz M., and Birklein F. Facilitated neurogenic inflammation in unaffected limbs of patients with complex regional pain syndrome. Neurosci. Lett. 359 (2004) 163-166
23. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16 (1988) 1215
24. Perez R.S., Zuurmond W.W., Bezemer P.D., Kuik D.J., van Loenen A.C., de Lange J.J., and Zuidhof A.J. The treatment of complex regional pain syndrome type I with free radical scavengers: a randomized controlled study. Pain 102 (2003) 297-307
25. Sakai A., Ujike H., Nakata K., Takehisa Y., Imamura T., Uchida N., Kanzaki A., Yamamoto M., Fujisawa Y., Okumura K., and Kuroda S. Association of the Neprilysin gene with susceptibility to late-onset Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 17 (2004) 164-169
26. Sandroni P., Benrud-Larson L.M., McClelland R.L., and Low P.A. Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study. Pain 103 (2003) 199-207
27. Schinkel C., Gaertner A., Zaspel J., Zedler S., Faist E., and Schuermann M. Inflammatory mediators are altered in the acute phase of posttraumatic complex regional pain syndrome. Clin. J. Pain 22 (2006) 235-239
28. Schwartz J.C., Malfroy B., and De La Baume S. Biological inactivation of enkephalins and the role of enkephalin-dipeptidyl-carboxypeptidase ("enkephalinase") as neuropeptidase. Life Sci. 29 (1981) 1715-1740
29. Schwartzman R.J. Reflex sympathetic dystrophy and causalgia. Neurol. Clin. 10 (1992) 953-973
30. Shipp M.A., and Look A.T. Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key!. Blood 82 (1993) 1052-1070
31. Stanton-Hicks M., Janig W., Hassenbusch S., Haddox J.D., Boas R., and Wilson P. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain 63 (1995) 127-133
32. Terwilliger J.D., and Ott J. Handbook of Human Genetic Linkage (1994), Johns Hopkins University Press, Baltimore
33. van Hilten J.J., van de Beek W.J., and Roep B.O. Multifocal or generalized tonic dystonia of complex regional pain syndrome: a distinct clinical entity associated with HLA-DR13. Ann. Neurol. 48 (2000) 113-116
34. Veldman P.H., and Goris R.J. Shoulder complaints in patients with reflex sympathetic dystrophy of the upper extremity. Arch. Phys. Med. Rehabil. 76 (1995) 239-242
35. Veldman P.H., Reynen H.M., Arntz I.E., and Goris R.J. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet 342 (1993) 1012-1016
36. Weber M., Birklein F., Neundorfer B., and Schmelz M. Facilitated neurogenic inflammation in complex regional pain syndrome. Pain 91 (2001) 251-257
37. Wei T., Li W.W., Guo T.Z., Zhao R., Wang L., Clark D.J., Oaklander A.L., Schmelz M., and Kingery W.S. Post-junctional facilitation of Substance P signaling in a tibia fracture rat model of complex regional pain syndrome type I. Pain 144 (2009) 278-286
38. Yamada M., Sodeyama N., Itoh Y., Takahashi A., Otomo E., Matsushita M., and Mizusawa H. Association of neprilysin polymorphism with cerebral amyloid angiopathy. J. Neurol. Neurosurg. Psychiatry 74 (2003) 749-751